Ocata Therapeutics, Inc.
DelistedCIK 1140098fmd_0ER2604G555GHM5QGTD2JMPET4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2015, 23 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 1 | – | – | – |
| Cost of revenue | 1 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 1 | 1 | 0 | 0 | 0 | 0 |
| Research and development | 4 | 7 | 10 | 14 | 12 | 11 |
| Total operating expenses | 12 | 33 | 17 | 26 | 30 | 35 |
| Operating income | (11) | (32) | (17) | (25) | (30) | (35) |
| Interest expense | 9 | 12 | 2 | 1 | 1 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (26) | (22) | (38) | (9) | (1) | 0 |
| Income before taxes | (37) | (54) | (55) | (35) | (31) | (35) |
| Income tax expense | – | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (55) | (35) | (31) | (35) |
| Net income | (37) | (54) | (55) | (35) | (31) | (35) |
| Net income to common shareholders | – | – | – | (37) | (33) | (37) |